LAS VEGAS, NV--(Marketwired - Jul 30, 2014) - Earth Science Tech, Inc. (OTCQB: ETST) ("ETST" or "the Company"), a unique biotechnology company focused on nutraceuticals, bioceuticals and dietary supplements, announced it has received the first major shipment of 25 liters of its Advanced High Grade CBD (Cannabidiol) Rich Hemp Oil. To view the photos taken of the delivered 25 liters visit: http://www.earthsciencetech.com/products. This scientifically formulated Advanced High Grade CBD (Cannabidiol) Rich Hemp Oil is regarded as "food based" and can be distributed in all 50 states and 40 countries as a nutritional and dietary supplement designed to support overall health and wellness. It is not marijuana so it does not require a medical license of any kind to authorize purchase. ETST's High Grade CBD Rich Hemp Oil is 100% natural and derived exclusively from the federally legal industrial hemp plant. Our innovative hemp cultivars, utilizing proprietary technologies, produce the Highest Grade and Quality CBD Rich Hemp Oil in the world. This natural and scientifically formulated oil is not only of the highest quality but is lab tested multiple times, from seed to distribution. This includes micro-biological testing, CBD profiling testing, other cannabinoid content testing, yeast, mold, fungus, and bacteria testing to ensure the utmost degree of safety and the highest quality available.
ETST has confirmed test results showing its High Grade CBD (Cannabidiol) Rich Hemp Oil is specifically supportive of overall health and wellness for the nutritional and dietary supplement markets. ETST is now capable of supplying and offering this Advanced High Grade CBD (Cannabidiol) Rich Hemp Oil at wholesale prices to resellers, third party distribution companies and/or consumers in all 50 states and 40 countries. With this advanced and innovative oil ETST has a significant cost advantage and ability to scale up in the CBD arena as a leading provider and wholesale distributor.
CEO of ETST, Harvey Katz, PhD, stated, "Our Advanced High Grade CBD (Cannabidiol) Rich Hemp Oil is designed to yield overall health and wellness benefits by utilizing CBD (Cannabidiol). As previously stated, our mission is to educate the public on the many and varied nutritional and health benefits of CBD (Cannabidiol) Rich Hemp Oil, to help optimize purity in formulation, and to find new product delivery systems. There's a lot of misconception in the marketplace right now with regard to the proper dosing and percentage of CBD (Cannabidiol) Rich Hemp Oil needed to be consumed as a nutritional and dietary supplement for overall health and wellness. We are here to help the market understand that with our advanced oil sometimes less is more, saving the consumer money and making dosing that much more affordable and effective. The market and most consumers don't realize that the proper dosing needed is much lower than might be expected to help with particular health disorders and conditions as well as general wellness. Furthermore, when it comes to percentages of CBD Oil, it doesn't really matter because what you need to look for is the CBD molecule content you are taking per dosage. If you focus on the CBD molecule content inside the industrial hemp base oil it makes it much easier to see what you are paying for CBD. More importantly, this makes dosing much easier and more effective and allows for huge cost savings if you use our Advanced High Grade CBD (Cannabidiol) Rich Hemp Oil as compared to others in the marketplace. ETST plans on developing certain guidelines for the correct dosages of its Advanced High Grade CBD (Cannabidiol) Rich Hemp Oil as a nutritional and dietary supplement to be used for various disorders and conditions through upcoming publications and clinical trials."
ETST welcomes and invites all interested parties to contact the company directly at email@example.com in regards to securing its Advanced High Grade CBD (Cannabidiol) Rich Hemp Oil. Furthermore ETST is also open to forming new strategic partnerships, joint ventures and/or supplying vendors, resellers and third party distribution companies its Advanced High Grade CBD (Cannabidiol) Rich Hemp Oil at wholesale prices in order to better help supply the health and wellness markets on a large scale. The company feels it can grow at a much faster pace by focusing on becoming a large wholesale distributor of its Advanced High Grade CBD (Cannabidiol) Rich Hemp Oil and by aligning itself with key strategic partners and third party resellers that are already well diversified in the nutritional and dietary supplement markets.
Additionally, ETST is pleased to announce its new corporate office is:
Earth Science Tech, Inc.
2255 Glades Road Suite 324A
Boca Raton, Florida 33431
To view the photos of the new corporate office location visit http://www.earthsciencetech.com/contact-us.
ABOUT ETST: ETST is a unique biotechnology company focused on delivering cutting edge nutraceuticals, bioceuticals and dietary supplements designed to excel in industries such as health, wellness, sports and alternative medicine so as to be a prominent factor in improving the quality of life for consumers worldwide. ETST is dedicated to providing natural alternatives to prescription medications such as nutritional supplements and dietary supplements that help improve common disorders and illnesses. This may include products such as vitamins, minerals, herbs, botanicals, personal care products, homeopathics, functional foods, CBD (Cannabidiol) as a natural constituent of hemp oil and other products. These products may be in various formulations and delivery forms including but not limited to capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders, and whole herbs.
ETST has an exclusive distribution agreement for the purchase of raw hemp-based CBD (Cannabidiol) rich oil. ETST does not grow, sell or distribute any substances that violate the laws of the United States or the controlled substance regulations of any state. ETST is focused on certain High Grade CBD (Cannabidiol) Rich Hemp Oil that is considered to be "food based" and therefore legal in all 50 states and more than 40 countries. Cannabinoids (cannabidiol/CBD) are natural constituents of the hemp plant, and CBD is derived from hemp stalk and seed. Hemp oil is a well-known dietary supplement and the naturally occurring CBD in hemp has provided overwhelming evidence of significant health and wellness benefits. CBD possesses no psychoactive properties and therefore is a ready for market non-THC hemp-based product. According to scientific and clinical studies, CBD has the potential to help a range of conditions, including epilepsy, diabetes, rheumatoid arthritis, chronic pain, alcoholism, schizophrenia, PTSD, antibiotic-resistant infections, and various neurological disorders (Source: National Center for Biotechnology Information http://www.ncbi.nlm.nih.gov). CBD has demonstrated neurogenic and neuroprotective effects and its anti-cancer properties are currently being investigated at several academic research centers in the United States and abroad.
The Food and Drug Administration (FDA) currently considers non-THC hemp-based Cannabinoids, including CBD, to be "food based" and therefore legal. These new non-psychoactive CBD-rich hemp oil products that ETST will look to market and distribute are completely lawful to distribute and available to consumers in all fifty states and in more than forty countries. CBD (Cannabidiol), a naturally-occurring constituent of the industrial hemp plant, promotes and supports the nutritional health of aging bodies. Source: US Government patent #6,630,507 "Cannabinoids as antioxidants and neuroprotectants."
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE: These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
FORWARD LOOKING DISCLAIMER: This release contains forward-looking statements that involve risks and uncertainties. Readers are referred to the Securities and Exchange Commission filings filed by the Company on EDGAR at http://www.sec.gov/edgar.shtml, specifically the most recent reports which identify important risk factors that could cause actual results to differ from those contained in the forward-looking statements. The Company undertakes no obligation to review or confirm analysts' expectations or estimates or to publicly release any revisions to any forward-looking statements. The information contained in this press release should not be construed as any indication of the Company's future stock price, its revenues or results of operations.